Join us online for a session exploring the advantages of focal therapy compared with traditional treatment approaches, including its minimally invasive nature, preservation of healthy prostate tissue, and reduced risk of side effects. In partnership with Chris O'Brien Lifehouse.

A recent trial of focal therapy using a novel cooled‑laser device in 100 patients has shown promising early outcomes. At three months post‑treatment, 84% of participants had no clinically significant prostate cancer on biopsy, alongside an improved safety profile and low rates of incontinence.

Presented by:

Dr Nari Ahmadi, Urologist and Cancer Surgeon, Robotic and Laparoscopic Urology, VMO at Chris O'Brien Lifehouse

Dr Nicholas Mehan, Urological Surgeon, Consultant at Nepean Urology Research Group, VMO at Chris O'Brien Lifehouse

Objectives of this talk:

• the role of focal therapy in prostate cancer management and how it compares with traditional treatment options
• patient benefits of focal therapy, including its minimally invasive nature, reduced side‑effect profile, and preservation of surrounding healthy prostate tissue
• clinical scenarios where focal therapy may be an appropriate consideration within the treatment pathway
• impact of treatment choice on patient experience, recovery, and long‑term quality of life

Target audience: GPs. This educational session is specifically designed for practicing GPs. However, Pharmacists, AHPs and Nurses, whose work aligns with this topic, are warmly invited to register.

Please note the topics and speakers are subject to change. Please check back for updated information.

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991